跳至主要内容
临床试验/NCT03938688
NCT03938688已完成不适用

Two-armed Single Blinded Non-inferiority Registry Based Randomized Control Trial Comparing Transfascial Sutures for Mesh Fixation to No Mesh Fixation for Open Retromuscular Repairs

The Cleveland Clinic1 个研究点 分布在 1 个国家目标入组 325 人开始时间: 2019年10月21日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
325
试验地点
1
主要终点
Recurrence

研究概览

简要总结

This will be a single blinded, registry based, non-inferiority, randomized control trial comparing transfacial sutures for mesh fixation to no mesh fixation in open retromuscular repairs. The primary outcome of interest is recurrence measured one year postoperatively as per standard of care at Cleveland Clinic Center for Abdominal Core Health. Hence, recurrence will be measured using either physical examination, CT scan, or the Ventral Hernia Recurrence Inventory (VHRI). Study population will include all adult patients (18 years or older) undergoing elective open ventral hernia repair of a clean (Wound class I) defect, where the midline fascia can be approximated and mesh will be placed in the retromuscular position. Only a midline approach to hernia repair and hernia widths equal to or less than 20cm measured intraoperatively will be included

详细描述

The techniques of mesh fixation in open incisional hernia repair is an active area of discussion and debate. When first described, the posterior component separation with the transversus abdominis muscle release involved placing the mesh in the retromuscular space, and fixating it circumferentially with transfascial sutures. These sutures penetrate the entire length of the abdominal wall and can be a significant source of pain. This study aims to evaluate the effect of using no fixation on recurrence rates, compared to the standard of care of using transfacial sutures. The investigators hypothesize that recurrences rates for patients who receive no fixation will be non-inferior to those receiving transfascial sutures.

This will be a single blinded, registry based, non-inferiority, randomized control trial comparing transfacial sutures for mesh fixation to no mesh fixation in open retromuscular repairs. This will be a two-arm trial with intervention 1: intervention 2 and control allocation ratio of 1:1. The Americas Hernia Society Quality Collaborative (AHSQC) will serve as the platform for data collection. The AHSQC is a multicenter, nationwide quality improvement effort with the mission of improving the quality of hernia care. Data points not recorded in the AHSQC will be collected by a trained research coordination or research fellow and uploaded into a Research Electronic Data Capture (RedCAP®) database hosted at the Cleveland Clinic

Study population will include all adult patients (≥ 18 years) undergoing elective open ventral hernia repair, where the midline fascia can be approximated and mesh will be placed in the retromuscular position. Only a midline approach to hernia repair and hernia widths equal to or less than 20cm measured intraoperatively will be included. Exclusion criteria include patients unable to give consent, vulnerable populations, parastomal hernias, hernia width measuring more than 20cm intraoperatively, patients planned for minimally invasive approaches or open repairs with mesh placed in a position other than retromuscular, or those who were not able to undergo successful retromuscular mesh placement. Finally, open repairs performed through a different incision than the standard midline approach will also be considered exclusion criteria, as well as the inability to close the midline fascia.

Study Interventions:

  • Intervention 1 (Control): Mesh will be placed in the retromuscular space, with wide overlap on all sides. Full thickness transfascial sutures will be placed circumferentially to secure the mesh using slowly absorbable no. 1 sutures. A total of six transfascial sutures will be placed universally for all patients with additional sutures allowed according to each surgeon's discretion. Additional bone or ligament sutures for mesh fixation will be allowed according to each surgeon's discretion.
  • Intervention 2: Mesh will be placed in the retromuscular space, with wide overlap on all sides. No fixation method will be used. Bone or ligament sutures for mesh fixation will not be allowed.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Undergoing elective open ventral hernia repair, where the midline fascia can be approximated and mesh will be placed in the retromuscular position
  • •A midline approach to hernia repair
  • •Hernia widths equal to or less than 20cm measured intraoperatively

排除标准

  • •Patients unable to give consent and vulnerable populations.
  • •Parastomal hernias
  • •Hernia width measuring more than 20cm intraoperatively
  • •Patients planned for minimally invasive approaches or open repairs with mesh placed in a position other than retromuscular, or those who were not able to undergo successful retromuscular mesh placement.
  • •Open repairs performed through a different incision than the standard midline approach
  • •Inability to close the midline fascia.

研究组 & 干预措施

Transfascial sutures for mesh fixation

Other

Mesh will be placed in the retromuscular space, with wide overlap on all sides. Full thickness transfascial sutures will be placed circumferentially to secure the mesh using slowly absorbable no. 1 sutures. A total of at least six transfascial sutures will be placed universally for all patients with additional sutures allowed according to each surgeon's discretion. Additional bone or ligament sutures for mesh fixation will be allowed according to each surgeon's discretion.

干预措施: Mesh placement with Transfascial Sutures (Procedure)

No mesh fixation

No Intervention

Mesh will be placed in the retromuscular space, with wide overlap on all sides. No fixation method will be used. Bone or ligament sutures for mesh fixation will not be allowed.

结局指标

主要结局

Recurrence

时间窗: One year

primary outcome of interest is recurrence measured one year postoperatively as per standard of care at the Cleveland Clinic Center for Abdominal Core Health. Hence, recurrence will be measured using either physical examination, CT scan, or the Ventral Hernia Recurrence Inventory (VHRI), either during a physical or a virtual clinic visit and/or using the telephone. The VHRI is a validated patient reported outcomes tool, a three-question survey that can be administered directly to patients without clinical interaction.

次要结局

  • Post-operative pain(Baseline, first 7 days post-operatively, and 30 day follow up. The 30-day follow up period will extend from 15 - 45 days postoperatively.)
  • Length of stay(From date of admission to hospital until the date of discharge from hospital, assessed up to 60 weeks)
  • Daily opioid requirements(first 7 days of the post-operative period)
  • Post-operative pain(Baseline and 30 day follow up. The 30-day follow up period will extend from 15 - 45 days postoperatively.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ajita Prabhu, MD

Assistant Professor of Surgery

The Cleveland Clinic

研究点 (1)

Loading locations...

相似试验

尚未招募
3 期
A clinical Trial to observe the efficacy of Homoeopathic Constitutional Medicine along with Calc Phos 6X in improving height of girls post menarche
CTRI/2023/09/057757Dr Priya sheth
终止
不适用
Registrational Trial to Compare Effectiveness of Two Digital Software Medical Devices as Adjunctive Oncology TreatmentAnatomic Stage II Breast Cancer AJCC v8Stage III Lung Cancer AJCC v8Stage II Lung Cancer AJCC v8Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8Stage I Lung Cancer AJCC v8
NCT04862195Blue Note Therapeutics31
进行中(未招募)
1 期
A study to compare the effects of fluticasone / formoterol BAI against Relvar® Ellipta® dry powder inhaler (DPI) on asthmaAsthma BronchialeMedDRA version: 19.1Level: PTClassification code 10003553Term: AsthmaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersMedDRA version: 19.1Level: LLTClassification code 10003555Term: Asthma bronchialSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersMedDRA version: 19.1Level: LLTClassification code 10068462Term: Eosinophilic asthmaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders
EUCTR2015-000801-38-SKMundipharma Research Limited90
进行中(未招募)
1 期
A study to compare the effects of fluticasone / formoterol BAI against Relvar® Ellipta® dry powder inhaler (DPI) on asthmaAsthma BroncialeMedDRA version: 18.1Level: LLTClassification code 10003555Term: Asthma bronchialSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersMedDRA version: 18.1Level: PTClassification code 10003553Term: AsthmaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersMedDRA version: 18.1Level: LLTClassification code 10068462Term: Eosinophilic asthmaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders
EUCTR2015-000801-38-SEMundipharma Research Limited120
已完成
Unknown
A study to evaluate the safety and efficacy of a test product in female subjects with varied skin type.
CTRI/2023/10/059282DPKA Universal Consumer Ventures Private Limited96